date,title,source
Nov-05-18,REGENXBIO and Abeona Therapeutics Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector,PR Newswire
Nov-05-18,Abeona Therapeutics and REGENXBIO Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector,GlobeNewswire
Nov-07-18,What Kind Of Share Price Volatility Should You Expect For Abeona Therapeutics Inc (NASDAQ:ABEO)?,Simply Wall St.
Nov-09-18,"Abeona Therapeutics (ABEO) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-09-18,Abeona Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-09-18,Abeona Therapeutics Reports Third Quarter 2018 Financial Results and Business Highlights,GlobeNewswire
Nov-13-18,Abeona Announces Participation at the Jefferies 2018 London Healthcare Conference,GlobeNewswire
Nov-13-18,Edited Transcript of ABEO earnings conference call or presentation 12-Nov-18 3:00pm GMT,Thomson Reuters StreetEvents
Nov-26-18,Abeona Therapeutics Announces CEO Transition,GlobeNewswire
Nov-27-18,"Analysis: Positioning to Benefit within Abeona Therapeutics, Great Lakes Dredge & Dock, Imprimis Pharmaceuticals, Alliant Energy, Cytokinetics, and Aurinia Pharmaceuticals  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Nov-29-18,"Abeona Therapeutics to Host R&D Day on December 6, 2018",GlobeNewswire
